The DOI matches its Crossref record; 70 of the 74 references it cites were found in a registry or an index, and 4 are not checked yet.
Requirement of Phosphatidylinositol 3-Kinase-Dependent Pathway and Src for Gas6-Axl Mitogenic and Survival Activities in NIH 3T3 Fibroblasts
Open accessAbstract
Gas6 is a secreted protein previously identified as the ligand of the Axl receptor tyrosine kinase. We have shown that Gas6 is able to induce cell cycle reentry of serum-starved NIH 3T3 cells and to efficiently prevent apoptosis after complete growth factor removal, a survival effect uncoupled from Gas6-induced mitogenesis. Here we report that the mitogenic effect of Gas6 requires phosphatidylinositol 3-kinase (PI3K) activity since it is abrogated both by the specific inhibitor wortmannin and by overexpression of the dominant negative P13K p85 subunit. Consistently, Gas6 activates the P13K downstream targets S6K and Akt, whose activation is abrogated by addition of wortmannin. Moreover, rapamycin treatment blocks Gas6-induced entry into the S phase of serum-starved NIH 3T3 cells. We also demonstrate the requirement of Src tyrosine kinase for Gas6 signalling since stable or transient expression of a catalytically inactive form of Src significantly inhibited Gas6-stimulated entry into the S phase. Accordingly, Gas6 addition to serum-starved NIH 3T3 cells causes activation of the intrinsic Src kinase activity. When specifically analyzed in a survival assay, these elements were found to be required for the survival effect of Gas6. Taken together, the evidence presented here identifies elements involved in the Gas6 transduction pathway that are responsible for its antiapoptotic effect and suggests that Src is involved in the events regulating cell survival.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This also leads to activation of NF-kB, which is thought to promote cell survival in fibroblasts and endothelial cells [147, 151, 152].”
From Microglial function, INPP5D/SHIP1 signaling, and NLRP3 inflammasome activation: implications for Alzheimer’s disease (2023) · cites this paper as [151]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Induction of apoptosis in fibroblasts by c-myc protein
Evan, G. I., Wyllie, A. H., Gilbert, C. S., Littlewood, T. D., Land, H., Brooks, M. W., Waters, C. M., Penn, L. Z., & Hancock, D. C. (1992) · Cell · doi:10.1016/0092-8674(92)90123-t · Cited by 2,941
Oncogenes and signal transduction
Cantley, L. C., Auger, K. R., Carpenter, C. F., Duckworth, B. C., Graziani, A., Kapeller, R., & Soltoff, S. P. (1991) · Cell · doi:10.1016/0092-8674(91)90639-g · Cited by 2,697
SH2 domains recognize specific phosphopeptide sequences
Songyang, Z. (1993) · Cell · doi:10.1016/0092-8674(93)90404-e · Cited by 2,620
Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction
Burgering, B. M. T., & Coffer, P. J. (1995) · Nature · doi:10.1038/376599a0 · Cited by 2,076
Franke, T. F., Yang, S., Chan, T. O., Datta, K., Kazlauskas, A., Morrison, D. K., Kaplan, D. R., & Tsichlis, P. N. (1995) · Cell · doi:10.1016/0092-8674(95)90534-0 · Cited by 2,001
PI3K: Downstream AKTion Blocks Apoptosis
Franke, T. F., Kaplan, D. R., & Cantley, L. C. (1997) · Cell · doi:10.1016/s0092-8674(00)81883-8 · Cited by 1,665
Programmed Cell Death and the Control of Cell Survival: Lessons from the Nervous System
RAFF, M. C., Barres, B. A., Burne, J. F., Coles, H., Ishizaki, Y., & Jacobson, M. D. (1993) · Science · doi:10.1126/science.8235590 · Cited by 1,450
Requirement for Phosphatidylinositol-3 Kinase in the Prevention of Apoptosis by Nerve Growth Factor
Yao, R., & Cooper, G. M. (1995) · Science · doi:10.1126/science.7701324 · Cited by 1,393
Receptor Protein-Tyrosine Kinases and Their Signal Transduction Pathways
van der Geer, P., Hunter, T., & Lindberg, R. A. (1994) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.10.110194.001343 · Cited by 1,351
Chung, J., Kuo, C. J., Crabtree, G. R., & Blenis, J. (1992) · Cell · doi:10.1016/0092-8674(92)90643-q · Cited by 1,151
Research works printed but not linked: 2
- Ohashi, K., K. Mizuno, K. Kuma, T. Miyata, and T. Nakamura. 1994. Cloning of the cDNA for a novel receptor tyrosine kinase. Oncogene 9:699–705.
- 10.1128/mcb.2.4.355-360.1982 · DOI
Cited by
Sorted by citations
Items 101–192 of 192
Yi, Z., Li, L., Matsushima, G. K., Earp, H. S., Wang, B., & Tisch, R. (2009) · Blood · doi:10.1182/blood-2009-03-207522 · Cited by 46
The SHBG‐like region of protein S is crucial for factor V‐dependent APC‐cofactor function
Nyberg, P., Dahlbäck, B., & de Frutos, P. G. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)00877-1 · Cited by 46
Kłosowska-Buryło, K., Volin, M. V., Huynh, N., Chong, K. K., Halloran, M. M., & Woods, J. M. (2009) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2009.03903.x · Cited by 46
Axl Receptor Axis: A New Therapeutic Target in Lung Cancer
Levin, P. A., Brekken, R. A., Byers, L. A., Heymach, J. V., & Gerber, D. E. (2016) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2016.04.015 · Cited by 46
Allen, M. P., Xu, M., Linseman, D. A., Pawlowski, J. E., Bokoch, G., Heidenreich, K. A., & Wierman, M. E. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200826200 · Cited by 46
Impact of Expression of Vimentin and Axl in Breast Cancer
Tanaka, K., Tokunaga, E., Inoue, Y., Yamashita, N., Saeki, H., Okano, S., Kitao, H., Oki, E., Oda, Y., & Maehara, Y. (2016) · Clinical Breast Cancer · doi:10.1016/j.clbc.2016.06.015 · Cited by 43
D’Arcangelo, D., Ambrosino, V., Giannuzzo, M., Gaetano, C., & Capogrossi, M. C. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.06.002 · Cited by 43
AXL receptor tyrosine kinase as a therapeutic target in NSCLC
Bivona, T. G., & Okimoto, R. A. (2015) · Lung Cancer Targets and Therapy · doi:10.2147/lctt.s60438 · Cited by 41
Ekman, C. J., Flondell-Sité, D., Gottsäter, A., Lindblad, B., & Dahlbäck, B. (2009) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2009.07.025 · Cited by 41
The role of Tyro 3 subfamily receptors in the regulation of hemostasis and megakaryocytopoiesis
Wang, H., Cnhen, S., Chen, Y., Wang, H., Wu, H., Tang, H., Xiong, W., Ma, J., Ge, Y., Lu, Q., et al. (2007) · Haematologica · doi:10.3324/haematol.10939 · Cited by 41
Goruppi, S., & Kyriakis, J. M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312401200 · Cited by 40
Self-citationBrown, M., Black, J. R., Sharma, R., Stebbing, J., & Pinato, D. J. (2016) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2016-203629 · Cited by 37
Ekman, C. J., Gottsäter, A., Lindblad, B., & Dahlbäck, B. (2010) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2010.04.006 · Cited by 38
Tyro3, Axl, Mertk receptor-mediated efferocytosis and immune regulation in the tumor environment
Zhou, L., & Matsushima, G. K. (2021) · International review of cytology · doi:10.1016/bs.ircmb.2021.02.002 · Cited by 35
Targeting MERTK and AXL in EGFR Mutant Non-Small Cell Lung Cancer
Yan, D., Earp, H. S., DeRyckere, D., & Graham, D. K. (2021) · Cancers · doi:10.3390/cancers13225639 · Cited by 35
AXL is a potential therapeutic target in dedifferentiated and pleomorphic liposarcomas
May, C. D., Garnett, J., Ma, X., Landers, S. M., Ingram, D. R., Demicco, E. G., Sannaa, G. A. A., Vu, T., Han, L., Zhang, Y., et al. (2015) · BMC Cancer · doi:10.1186/s12885-015-1916-3 · Cited by 34
Dynamics of Axl Receptor Shedding in Hepatocellular Carcinoma and Its Implication for Theranostics
Holstein, E., Binder, M., & Mikulits, W. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19124111 · Cited by 33
Divine, L. M., Nguyen, M. R., Meller, E. H., Desai, R. A., Arif, B., Rankin, E. B., Bligard, K. H., Meyerson, C., Hagemann, I. S., Massad, M., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.12637 · Cited by 32
Paccez, J. D., Duncan, K., Vava, A., Correa, R. G., Libermann, T. A., Parker, M. I., & Zerbini, L. F. (2015) · Molecular Biology of the Cell · doi:10.1091/mbc.e14-04-0868 · Cited by 32
Yan, S., Vandewalle, N., Beule, N. D., Faict, S., Maes, K., Bruyne, E. D., Menu, E., Vanderkerken, K., & Veirman, K. D. (2019) · Cancers · doi:10.3390/cancers11111727 · Cited by 32
TAM receptor deficiency affects adult hippocampal neurogenesis
Ji, R., Meng, L., Li, Q., & Lu, Q. (2014) · Metabolic Brain Disease · doi:10.1007/s11011-014-9636-y · Cited by 36
Linger, R. M. A., DeRyckere, D., Brandão, L., Sawczyn, K. K., Jacobsen, K. M., Liang, X., Keating, A. K., & Graham, D. K. (2009) · Blood · doi:10.1182/blood-2009-03-209247 · Cited by 32
RetractedDiscovery of N-[4-(Quinolin-4-yloxy)phenyl]benzenesulfonamides as Novel AXL Kinase Inhibitors
Szabadkai, I., Torka, R., Garamvölgyi, R., Baska, F., Gyulavári, P., Boros, S., Illyés, E., Choidas, A., Ullrich, A., & Őrfi, L. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00672 · Cited by 31
Allen, M. P., Xu, M., Zeng, C. X., Tobet, S. A., & Wierman, M. E. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m007097200 · Cited by 31
Novel vitamin K-dependent pathways regulating cell survival
Saxena, S. P., Israels, E. D., & Israels, L. G. (2001) · APOPTOSIS · doi:10.1023/a:1009624111275 · Cited by 30
A xl/ G as6 pathway positively regulates FLT3 activation in human natural killer cell development
Park, I., Trotta, R., Yu, J., & Caligiuri, M. A. (2013) · European Journal of Immunology · doi:10.1002/eji.201243116 · Cited by 29
Maacha, S., Hong, J., von Lersner, A. K., Zijlstra, A., & Belkhiri, A. (2018) · Neoplasia · doi:10.1016/j.neo.2018.08.005 · Cited by 29
Dambrin, C., Klupp, J., Bı̂rsan, T., Luna, J., Suzuki, T., Lam, T. T., Stähr, P., Hausen, B., Christians, U., Fitzgerald, P. J., et al. (2003) · Circulation · doi:10.1161/01.cir.0000065576.80196.a4 · Cited by 28
Pénzes, K., Baumann, C., Szabadkai, I., Őrfi, L., Kéri, G., Ullrich, A., & Torka, R. (2014) · Cancer Biology & Therapy · doi:10.4161/15384047.2014.956634 · Cited by 28
Mills, K. A., Quinn, J. M., Roach, S. T., Palisoul, M. L., Nguyen, M. R., Noia, H. M., Guo, L., Fazal, J. A., Mutch, D. G., Wickline, S. A., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-41122-3 · Cited by 27
AXL, an Important Host Factor for DENV and ZIKV Replication
Xie, S., Zhang, H., Liang, Z., Yang, X., & Cao, R. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.575346 · Cited by 25
Yin, J. L., Pilmore, H., Yan, Y. Q., McCaughan, G. W., Bishop, G. A., Hambly, B. D., & Eris, J. (2002) · Transplantation · doi:10.1097/00007890-200202270-00032 · Cited by 25
TAM kinases as regulators of cell death
Post, S. M., Andreeff, M., Dinardo, C. D., Khoury, J. D., & Ruvolo, P. P. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2021.118992 · Cited by 22
Haase, T. N., Rasmussen, M., Jaksch, C., Gaarn, L. W., Petersen, C., Billestrup, N., & Nielsen, J. H. (2013) · Diabetologia · doi:10.1007/s00125-012-2821-9 · Cited by 23
Therapeutic Landscape of AXL Receptor Kinase in Triple-Negative Breast Cancer
Özyurt, R., & Özpolat, B. (2023) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-22-0617 · Cited by 29
Woo, S. M., Min, K., Seo, S. U., Kim, S., Kubatka, P., Park, J., & Kwon, T. K. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20133253 · Cited by 22
Laurance, S., Aghourian, M. N., Lila, Z. J., Lemarié, C. A., & Blostein, M. D. (2013) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12481 · Cited by 20
Plasma concentrations of sAxl are associated with severe preeclampsia
Liu, X., Gong, Y., Jia, J., Bai, Y., Gui, S., Wang, T., & Zhou, R. (2013) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2013.11.001 · Cited by 20
She, Q., Mukherjee, J. J., Chung, T., & Kiss, Z. (2000) · Cellular Signalling · doi:10.1016/s0898-6568(00)00117-0 · Cited by 20
From MASH to HCC: the role of Gas6/TAM receptors
Apostolo, D., Ferreira, L. L., Vincenzi, F., Vercellino, N., Minisini, R., Latini, F., Ferrari, B., Burlone, M. E., Pirisi, M., & Bellan, M. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1332818 · Cited by 19
Role of Cathelicidin Peptides in Bovine Host Defense and Healing
Tomasinsig, L., Benincasa, M., Scocchi, M., Skerlavaj, B., Tossi, A., Zanetti, M., & Gennaro, R. (2010) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-010-9035-6 · Cited by 19
Lee, Y. J., Park, M., Kim, H., Kim, J., Kim, W., Lim, S., & Kang, K. W. (2022) · Acta Pharmacologica Sinica · doi:10.1038/s41401-022-01029-8 · Cited by 19
Yin, J. L., Hambly, B. D., Bao, S. S., Painter, D. M., Bishop, G. A., & Eris, J. (2003) · Transplant International · doi:10.1007/s00147-003-0593-3 · Cited by 18
Prevention of v-Ha-Ras-Dependent Apoptosis by PDGF Coordinates in Phosphorylation of ERK and Akt
Arase, Y., Hiwasa, T., Hasegawa, R., Nomura, J., Ito, H., & Suzuki, N. N. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1857 · Cited by 18
Two-Front War on Cancer—Targeting TAM Receptors in Solid Tumour Therapy
Mikołajczyk, A., Mituła, F., Popiel, D., Kaminska, B., Wieczorek, M., & Pieczykolan, J. (2022) · Cancers · doi:10.3390/cancers14102488 · Cited by 20
Chiang, C.-K., Tworak, A., Kevany, B. M., Xu, B., Mayne, J., Ning, Z., Figeys, D., & Palczewski, K. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.812677 · Cited by 17
Akt mediates insulin rescue from apoptosis in brown adipocytes: effect of ceramide
Navarro, P., Valverde, Á. M., Rohn, J. L., Benito, M., & Lorenzo, M. (2000) · Growth Hormone & IGF Research · doi:10.1054/ghir.2000.0165 · Cited by 17
Vitamin K Dependent Proteins of Bone and Cartilage
Gundberg, C. M., & Nishimoto, S. K. (2006) · Elsevier eBooks · doi:10.1016/b9-78-012088-5/62650-0042 · Cited by 17
Hong, J., Maacha, S., & Belkhiri, A. (2018) · Molecular Oncology · doi:10.1002/1878-0261.12395 · Cited by 16
High incidence of distal vaginal atresia in mice lacking Tyro3 RTK subfamily
Wu, H., Tang, H., Chen, Y., Wang, H., & Han, D. (2008) · Molecular Reproduction and Development · doi:10.1002/mrd.20917 · Cited by 15
Patel, A. B., Pomicter, A. D., Yan, D., Eiring, A. M., Antelope, O., Schumacher, J. A., Kelley, T. W., Tantravahi, S. K., Kovacsovics, T. J., Shami, P. J., et al. (2020) · Leukemia · doi:10.1038/s41375-020-0858-1 · Cited by 17
Huang, J., Mukherjee, J. J., & Kiss, Z. (1999) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1999.1203 · Cited by 15
Influence of leptin and compression in GAS‐6 mediated homeostasis of periodontal ligament cell
Yong, J., Groeger, S. E., Ruf, S., & Ruiz‐Heiland, G. (2021) · Oral Diseases · doi:10.1111/odi.14092 · Cited by 14
Novel Tyrosine Kinase Targets in Urothelial Carcinoma
Torres-Jiménez, J., Albarrán-Fernández, V., Pozas, J., Román-Gil, M. S., Esteban-Villarrubia, J., Carrato, A., Rosero, A., Grande, E., Alonso-Gordoa, T., & Molina-Cerrillo, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020747 · Cited by 14
Effect of AXL on the epithelial-to-mesenchymal transition in non-small cell lung cancer
Ying, X., Chen, J., Huang, X., Huang, P., & Yan, S.-C. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.4532 · Cited by 13
AXL Tyrosine Kinases: A Growing Isoform Family That Promotes Cancer Pathogenesis
Gjerstad, M. E., Aehnlich, P., Gélébart, P., & McCormack, E. (2025) · Cancer Research · doi:10.1158/0008-5472.can-24-3841 · Cited by 12
Voisin, A., Gaillard, A., Balbous, A., & Leveziel, N. (2022) · Antioxidants · doi:10.3390/antiox11040713 · Cited by 11
John, L., George, M., Dcunha, L., Nisar, M., Sanjeev, D., Pahal, P., Gopalakrishnan, A. P., Shivamurthy, P. B., Sreelan, S., Yandigeri, T., et al. (2024) · Journal of Proteins and Proteomics · doi:10.1007/s42485-024-00147-7 · Cited by 10
Essential role of Gas6 for glomerular injury in nephrotoxic nephritis
Yanagita, M., Ishimoto, Y., Arai, H., Nagai, K., Ito, T., Nakano, T., Salant, D. J., Fukatsu, A., Doi, T., & Kita, T. (2002) · Journal of Clinical Investigation · doi:10.1172/jci200214861 · Cited by 9
Yan, D., Shao, R., & Hung, M. (2002) · Elsevier eBooks · doi:10.1016/b978-012437551-2/50031-8 · Cited by 9
Molecular analysis of alternative transcripts of equine AXL receptor tyrosine kinase gene
Park, J.-W., Song, K., Kim, N.-Y., Choi, J., Hong, S. A., Oh, J. H., Kim, S. W., Lee, J. H., Park, T. S., Kim, J., et al. (2017) · Asian-Australasian Journal of Animal Sciences · doi:10.5713/ajas.17.0409 · Cited by 8
Jiang, H., Lee, K. K., Schneider, C., O, W. S., Tang, P. L., & Chow, P. K. H. (2001) · Anatomy and Embryology · doi:10.1007/s004290100159 · Cited by 8
Self-citationThe role of MerTK in promoting cell migration is enhanced by the oncogenic Ras/IL‐33 signaling axis
Ohta, S., Tago, K., Kuchimaru, T., Funakoshi‐Tago, M., Horie, H., Aoki‐Ohmura, C., Matsugi, J., & Yanagisawa, K. (2021) · FEBS Journal · doi:10.1111/febs.16271 · Cited by 6
Role of axl in preeclamptic EPCs functions
Hu, Y., Liu, X., Liu, X., Zheng, Y., Liu, W.-F., Luo, M., Gao, H. Y., Zhao, Y., & Zou, L. (2016) · Journal of Huazhong University of Science and Technology [Medical Sciences] · doi:10.1007/s11596-016-1598-3 · Cited by 6
GABARAP is a determinant of apoptosis in growth-arrested chicken embryo fibroblasts
Maynard, S., Ghosh, R., Wu, Y., Shi, Y., Miyake, T., Gagliardi, M., Rethoret, K., & Pa, B. (2014) · Journal of Cellular Physiology · doi:10.1002/jcp.24889 · Cited by 5
Yu, W., Ge, X., Lai, X., Lv, J., & Wang, Y. (2019) · Europe PMC (PubMed Central) · Cited by 4
YU, D.-P., Dong, Y., ZHANG, H.-Q., Wang, J., Qu, Y., ZHOU, L.-J., SU, D., ZHANG, L.-L., Zhao, D., & Cai, Y. (2014) · Biomedical Reports · doi:10.3892/br.2014.261 · Cited by 4
Lemke, G. (2015) · Springer eBooks · doi:10.1007/978-3-319-11888-8_2 · Cited by 3
Kishi, Y., Funakoshi, H., Matsumoto, K., & Nakamura, T. (2002) · Gene · doi:10.1016/s0378-1119(02)00483-3 · Cited by 3
Beug, S. T., Vascotto, S. G., & Tsilfidis, C. (2006) · Developmental Dynamics · doi:10.1002/dvdy.20690 · Cited by 3
Increased Activity of c-Src and Csk in Fibroblasts Transformed by v-src Oncogene
Tuháčková, Z., Vojtěchová, M., Hlaváček, J., Ruzzene, M., Sovová, V., & Pinna, L. A. (2002) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.6247 · Cited by 3
Cai, Y., Dong, Y., Wu, H., Yu, D., Zhou, L., Su, D., Zhang, L., & Chen, X.-J. (2016) · Oncology Letters · doi:10.3892/ol.2016.5080 · Cited by 2
Axl and Its Mediated Signaling Axis in Cancer
Mudduluru, G. (2017) · Springer eBooks · doi:10.1007/978-3-319-53659-0_3 · Cited by 2
Vitamin K-dependent carboxylation in osteoblasts regulates bone resorption through GAS6 in male mice
Pata, M., Pham, D. N. T., Lacombe, J., Reddy, B. A., Kim, Y. W., Ahmed, A., Murshed, M., & Ferron, M. (2026) · Bone Research · doi:10.1038/s41413-026-00528-2 · Cited by 1
Drivers of EMT and Immune Evasion
Brekken, R. A., & Wnuk-Lipińska, K. (2017) · Springer eBooks · doi:10.1007/978-3-319-39147-2_9 · Cited by 1
TAM family proteins and therapy resistance
McDaniel, N. K., Fischbach, S. R., Ondracek, O. J., Welke, N. B., Iida, M., & Wheeler, D. L. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-817868-3.00008-1 · Cited by 1
Drivers of EMT and Immune Evasion
Brekken, R. A., & Wnuk-Lipińska, K. (2022) · Springer eBooks · doi:10.1007/978-3-030-98950-7_11 · Cited by 1
Effects of Nutrient Deprivation on the Expression of Growth-Arrest Genes
Rees, W. D. (2005) · Oxidative stress and disease · doi:10.1201/9781420028362.ch6
Song, X. (2011) · Digital Commons-TMC (Texas Medical Center)
Caracterització del gen GAS6 i associació amb malalties humanes
Miralles, X. M. I. (2006) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
A multifaceted study of the receptor tyrosine kinase Axl with focus on Renal Cell Carcinoma
Gustafsson, A. (2009) · Lund University Publications (Lund University)
Axl RTK and microRNAs in urogenital cancers
Fritz, H. (2015) · Lund University Publications (Lund University)
Dynamic regulation of thrombus stability : focus on platelet receptors and downstream signaling
Cosemans, J. M. E. M. (2009) · doi:10.26481/dis.20090129jc
Evaluation of MERTK evolution and efferocytosis signalling
Evans, A. (2016) · Scholarship@Western (Western University)
High glucose induces human endothelial dysfunction through an Axl-dependent mechanism
Lee, C.-H., Shieh, Y., Hsiao, F., Kuo, F.-C., Lin, C.-Y., Hsieh, C., & Hung, Y. (2016) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(16)31097-x
Mer receptor expression promotes multiple myeloma disease development via a cell-extrinsic mechanism
Clark, J. R., Panagopoulos, V., Noll, J. E., Mrozik, K. M., Bradey, A. L., Croucher, P. I., Zannettino, A. C. W., Vandyke, K., & Hewett, D. R. (2025) · Experimental Hematology · doi:10.1016/j.exphem.2025.104842
Identification de nouvelles voies de signalisation activées dans les léiomyosarcomes
Sayadi, H. E. (2009) · theses.fr (ABES) · doi:10.70675/db9667baz4bd2z4752zb69az46882adce556
Identification et optimisation de nouvelles séries chimiques anti-kinases
Feneyrolles, C. (2014) · theses.fr (ABES) · doi:10.70675/2ec89e77zde93z4684zbd60zb6f7afa532b9
Signalisation et ciblage thérapeutique du récepteur tyrosine kinase AXL dans les cancers
Leconet, W. (2014) · theses.fr (ABES) · doi:10.70675/e91475a6z3b26z42ecza153zdc13a97fb5ec
Santiago (2001) · doi:10.1002/1529-0131(200107)44:7
Metadata
- Authors
- Goruppi, S., Ruaro, E., Varnum, B., & Schneider, C.
- Affiliations
- Amgen (United States) (US)
- Consorzio Interuniversitario per le Biotecnologie (IT)
- University of Udine (IT)
- ORCID
- Goruppi, Sandro
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 1997-08
- Volume
- 17
- Issue
- 8
- Pages
- 4442-4453
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- PMC
- PMC232298
- OpenAlex
- W2119376722
- Cited by
- 191
- References
- 70
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 2 · 2023: 2 · 2022: 5 · 2021: 8 · 2020: 4 · 2019: 6 · 2018: 5 · 2017: 6 · 2016: 10 · 2015: 5 · 2014: 9 · 2013: 9 · 2012: 4
- FWCI
- 2.49
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Molecular and Cellular Biology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Institutional Research Information System (University of Udine) (submittedVersion)
- Funders
- Associazione Italiana per la Ricerca sul Cancro
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Keywords
- Gas6, AXL receptor, phosphatidylinositol 3-kinase, Src kinase, cell survival signaling, mitogenesis, apoptosis inhibition, S6K, Akt, wortmannin, rapamycin, cell cycle re-entry, S phase entry, NIH3T3 cells, receptor tyrosine kinase signaling
- MeSH terms
- Wortmannin, Axl Receptor Tyrosine Kinase, Growth Arrest-Specific Protein 6, Androstadienes, Animals, Cell Survival, Enzyme Activation, Enzyme Inhibitors, Mitogens, Phosphorylation, Polyenes, Proteins, Proto-Oncogene Proteins, Receptors, Cell Surface, Signal Transduction, Oncogene Proteins, Proto-Oncogene Proteins pp60(c-src), 3T3 Cells, Protein Serine-Threonine Kinases, Phosphotransferases (Alcohol Group Acceptor), Phosphatidylinositol 3-Kinases, Ribosomal Protein S6 Kinases, Sirolimus, Receptor Protein-Tyrosine Kinases, Intercellular Signaling Peptides and Proteins, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review